Stick to Your Plan<br />By Rev Shark<br />RealMoney.com Contributor<br />9/16/2009 8:16 AM EDT <br /><br />Moderation is a fatal thing. Nothing succeeds like excess. <br />-- Oscar Wilde<br /><br />It is becoming extremely difficult to offer new insights into this market. It seems like every day lately the action has been the same. The positive conditions have been unchanged for weeks now, with the only real negative being that we have steadily become more extended. The bearish fundamental arguments are sounding almost ridiculous in the face of this strength, and technical concerns like being "overbought" are just distractions that prevent us from embracing a market that doesn't rest. <br /><br />My position for a while has been that we have to respect the uptrend and the momentum, no matter how unjustified we think it might be. The biggest positive this market has going for it is that there are so many frustrated folks who have never been able to fully embrace the strength. The market refused to pull back and let them in, and even the biggest bulls out there realize that new entries at this point are not particularly prudent. <br /><br />So what do we do now? The most important thing is to not let frustration make you undisciplined. If your style isn't to pay up for a stock that has gone straight up for eight days in a row, don't start buying it now. If you have been bearish, set some stops and don't let losses get out of hand. <br /><br />Although they're rare, some individual stocks aren't horribly extended, and market players are going to be seeking them out. However, the opportunities to put new money to work are limited; the important thing is to stay disciplined and patient. One thing I can tell you with great certainty is that the market mood will eventually shift and all these stocks that look like they will never pull back will look quite different. <br /><br />Overseas markets were strong again, we have a positive open on the way and there doesn't seem to be any news causing any great worry or concerns. Gold stocks are looking particularly strong in the early going and are of particular interest to me -- they aren't quite as extended as many other things in the market. <br />-----------------------------<br />Ülespoole avanevad:<br /><br />In reaction to strong earnings/guidance: ROG +7.4%, RMBS +4.5%, SLAB +0.8%... M&A news: OMTR +27.0% (being acquired by Adobe for $21.50 in cash)... Select financial related names showing strength: AEG +5.3%, C +4.4% (said to consider weaning from FDIC Debt Guarantees - Bloomberg.com), HBC +4.0%, GNW +2.7%, ING +2.5%, LYG +2.4% (Brussels may force Lloyds to surrender Halifax - Times of London), AIG +1.9%, UBS +1.7%, BAC +1.3%, AZ +1.3%, WFC +0.8% (CEO says Wachovia integration "is on plan" - WSJ)... Select metals/mining names trading higher: : HL +6.1%, GOLD +4.4%, HMY +4.0%, AUY +3.9%, DROOY +3.5%, RTP +3.0%, GFI +2.1%, ABX +2.0%, AU +1.7%, BBL +1.5%, VALE +1.5%, BHP +1.5%, GLD +1.0%... Select casino related names seeing early strength: LVS +2.8%, MPEL +2.7%, MGM +1.9% (MGM Mirage discussed in Business Week), WYNN +1.4%... Other news: CVM +27.9% (to Commence First Clinical Study with Hospitalized H1N1 Infected Patients), NBIX +16.3% (Secures Committed Equity Financing Facility), IVAN +14.9% (announces a major technical breakthrough in the ongoing enhancement of the company's proprietary HTL technology), ACAS +10.9% (GLW announces that it has acquired all the shares of Axygen BioScience and its subsidiaries from American Capital), FLEX +10.1% (Cramer makes positive comments on MadMoney), OCLS +9.5% (announces new partnership agreement with V&M Industries for Microcyn-based OTC human wound care products), AEHR +8.9% (receives follow-on order for its FOX-15 wafer-level burn-in and test system from Micronas), SVNT +7.1% (confirms early 2010 target for KRYSTEXXA resubmission), CTIC +6.5% (released updated 18-month follow-up clinical data for its phase III EXTEND trial of pixantrone), YRCW +6.1% (still checking), HEB +6.0% (Board of Directors authorizes "multimillion dollar expansion" of its FDA licensed manufacturing facilities), NTCT +5.9% (will replace Bankrate in the S&P SmallCap 600 after the close of trading on Wednesday), APC +5.3% (announced a deepwater discovery at the Venus exploration well), QGEN +4.4% (still checking), AXL +3.8% (discloses it entered into a fourth extension of the Waiver and Amendment to Credit Agreement), NOK +2.0% (still checking), AAPL +1.6% (Cramer makes positive comments on MadMoney)... Analyst comments: WMG +10.1% (upgraded to Buy at Citigroup), TTWO +6.3% (upgraded to Overweight from Neutral at Piper Jaffray), CAL +4.6% (upgraded to Buy at Argus), DRIV +4.3% (upgraded to Outperform at Credit Suisse), AMZN +2.5% (upgraded to Buy from Neutral at BofA/Merrill), SNV +2.3% (upgraded to Neutral from Underperform at BofA/Merrill), FO +2.2% (upgraded to Buy from Neutral at Goldman- DJ), GRMN +2.0% (upgraded to Hold from Sell at Deutsche), OLN +1.5% (upgraded to Neutral from Sell at UBS).<br /><br />Allapoole avanevad:<br /><br />In reaction to disappointing earnings/guidance: PGI -7.6% (also downgraded to Market Perform from Outperform at Northland Securities), AGCO -6.5%, ADBE -4.5% (also announces deal to acquire Omniture; downgraded to Hold from Buy at Jefferies), CGA -1.3%... Other news: IRE -2.7% (Ireland seeks to bring bad property loans home - WSJ), VGR -4.2% (trading ex dividend and split), CUZ -3.7% (priced its public offering of 40 mln shares of common stock at a price to the public of $7.25 per share), VICL -3.7% (still checking), MSO -2.9% (still checking), NVAX -2.9% (files for a 3.4 mln common stock offering), SSL -2.6% (still checking), VGZ -2.1% (priced its 8.8 mln share common stock offering at $2.25/share), WFSL -1.8% (priced public offering of 21 million shares of its common stock at a public offering price of $14.50 per share)... Analyst comments: MIR -3.3% (downgraded to Sell from Hold at Citigroup), ITT -3.2% (downgraded to Neutral at Baird), MSO -2.9% (downgraded to Underweight at JPMorgan), LOGI -2.1% (downgraded to Sell from Neutral at Goldman- DJ), EM -2.1% (initiated with a Sell at Brean Murray), VZ -1.6% (downgraded to Neutral at UBS), DGX -1.5% (downgraded to Neutral at Credit Suisse), STM -1.2% (downgraded to Neutral from Buy at Goldman- DJ).